Patent · US Active

Ghrelin binding nucleic acids

US8101734B2 · kind B2 · utility

0Cited by

2References

11Claims

0Family size

Assignee

NOXXON Pharma AG · DE

Inventors

Florian Jarosch · Berlin, DE
Dirk Eulberg · Berlin, DE
Christian Maasch · Berlin, DE
Steffen Helmling · Boston, US
Sven Klussmann · Berlin, DE

Key dates

Filing date	Apr 7, 2006
Grant date	Jan 24, 2012
Priority date	—
Expiry date	Mar 21, 2027

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is related to a nucleic acid, preferably binding to ghrelin, whereby the nucleic acid comprises

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.